Avai Bio, Inc.

AVAIOTCTechnology● Active

$0.20

+$0.02(+9.72%)

Market Cap$27304770

P/E Ratio—

52W High$0.828

52W Low$0.16

Avg Volume143K

Open$0.17

Beta0.78

Free Cash Flow Financials Revenue

Avai Bio, Inc. (AVAI) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

AVAI · free cash flow · updated Jun 9, 2026

Core FCF metrics

AVAI · FCF · TTM · margin & CAGR

Free cash flow was −$1.2M for FY2025 (fiscal year ending 2025-03-31), up 21.1% year-over-year

FY2025 Free Cash Flow−$1.2M▲ +21.1% YoY

Trailing 12M (TTM)−$1.1Mtrailing 4 quarters sum

FCF Margin——

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

AVAI · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$1.2M(0M)−$1.2M▲ +21.1%—

FY2024−$1.3M(0M)−$1.5M▼ 1572.6%—

FY2023−$54,457(0M)−$87,967▲ +42.6%-31.8%

FY2022−$153,166(0M)−$153,166▼ 847.3%-16.6%

FY2021−$16,169(0M)−$16,169▲ +90.5%-1.3%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

AVAI · P/FCF · FCF yield · FCF per share

Avai Bio, Inc. (AVAI) reported negative free cash flow of −$0.00B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-03-31

Cash flow statement summary

AVAI · cash flow statement · operating / investing / financing

For FY2025, Avai Bio, Inc. generated −$1.2M in operating cash flow and spent 0M in capital expenditures, yielding −$1.2M in free cash flow.

Operating Activities

−$1.2M

Cash from core business operations

2025-03-31

Investing Activities

+$0.0M

CapEx, acquisitions & investments

2025-03-31

Financing Activities

+$1.2M

Buybacks, dividends & debt

2025-03-31

FCF FormulaOperating CF (−$1.2M) − |CapEx| (0M) = FCF (−$1.2M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Technology)

AVAI vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Avai Bio, Inc.YOU

AVAI

−$1.2M+21.1%—

Loss

Taiwan Semiconductor Manufacturing Company Limited

Microsoft Corporation

Technology · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Avai Bio, Inc. (AVAI) reported free cash flow of −$1.2M for FY2025 (fiscal year ending 2025-03-31), up 21.1% year-over-year.

Avai Bio, Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 8 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

AVAI free cash flow · 8 questions

Avai Bio, Inc. free cash flow was −$1.2M for FY2025, up 21.1% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$1.1M.

AVAI free cash flowAVAI FCFAVAI FCF 2025AVAI free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Avai Bio, Inc. · Avai Bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026